DrugPatentWatch Database Preview
Avelumab - Biologic Drug Details
Summary for avelumab
| Tradenames: | 1 |
| Patents: | 24 |
| Applicants: | 1 |
| BLAs: | 2 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for avelumab |
Recent Clinical Trials for avelumab
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Institut Paoli-Calmettes | Phase 2 |
| Southwest Oncology Group | Phase 2 |
| Oncolytics Biotech | Phase 2 |
Patent Text Search: US Patents for avelumab
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emd Serono Inc | BAVENCIO | avelumab | INJECTABLE;INJECTION | 761049 | 001 | 2017-04-25 | Start Trial | 2039-02-26 | RX | Orphan | search | |
| Emd Serono Inc | BAVENCIO | avelumab | INJECTABLE;INJECTION | 761049 | 001 | 2017-04-25 | Start Trial | Biomed Valley Discoveries, Inc. (Kansas City, MO) | 2035-06-29 | RX | Orphan | search |
| Emd Serono Inc | BAVENCIO | avelumab | INJECTABLE;INJECTION | 761049 | 001 | 2017-04-25 | Start Trial | IBC Pharmaceuticals, Inc. (Morris Plains, NJ) | 2032-08-14 | RX | Orphan | search |
| Emd Serono Inc | BAVENCIO | avelumab | INJECTABLE;INJECTION | 761049 | 001 | 2017-04-25 | Start Trial | Yeda Research and Development Co. Ltd. (Rehovot, IL) | 2034-03-12 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for avelumab
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2010326004 | Start Trial |
| Japan | 2011012083 | Start Trial |
| World Intellectual Property Organization (WIPO) | 2017004079 | Start Trial |
| China | 102481348 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
